Article
Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
Journal of immunoassay & immunochemistry - 1 Jan 2007
Redwan El-Rashdy M, Tabll Ashraf
Abstract excerpt
Hepatitis C virus (HCV) is a serious worldwide health risk and, to date, no effective treatments to prevent progression to chronic infection have been discovered. To combat the disease, Egyptian patients often use traditional medicines, for instance, camel milk, which contains lactoferrin. Currently, lactoferrin is one of the primary biopharmaceutical drug candidates against HCV infection. Camel lactoferrin (cLf)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
